Neutralizing activity and SARS-CoV-2 vaccine mRNA persistence in serum and breastmilk after BNT162b2 vaccination in lactating women

KT Yeo, WN Chia, CW Tan, C Ong, JG Yeo… - Frontiers in …, 2022 - frontiersin.org
Background There is limited information on the functional neutralizing capabilities of
breastmilk SARS-CoV-2-specific antibodies and the potential adulteration of breastmilk with …

[HTML][HTML] Neutralizing antibodies and cytokines in breast milk after coronavirus disease 2019 (COVID-19) mRNA vaccination

V Narayanaswamy, BT Pentecost… - Obstetrics & …, 2022 - journals.lww.com
OBJECTIVE: To evaluate immune responses to coronavirus disease 2019 (COVID-19)
mRNA-based vaccines present in breast milk and transfer of the immune responses to …

Comparison of SARS-CoV-2-specific antibodies in human milk after mRNA-based COVID-19 vaccination and infection

HG Juncker, SJ Mulleners, MJ van Gils, TPL Bijl… - Vaccines, 2021 - mdpi.com
SARS-CoV-2-specific antibodies are secreted into human milk of infected or vaccinated
lactating women and might provide protection to the breastfed infant against COVID-19 …

Detection of SARS-CoV-2–Specific Antibodies in Human Breast Milk and Their Neutralizing Capacity after COVID-19 Vaccination: A Systematic Review

V Nicolaidou, R Georgiou, M Christofidou… - International Journal of …, 2023 - mdpi.com
SARS-CoV-2 is the virus that causes the infectious disease known as Corona Virus Disease
2019 (COVID-19). The severe impact of the virus on humans is undeniable, which is why …

Codominant IgG and IgA expression with minimal vaccine mRNA in milk of BNT162b2 vaccinees

JM Low, Y Gu, MSF Ng, Z Amin, LY Lee, YPM Ng… - npj Vaccines, 2021 - nature.com
Lactating women can produce protective antibodies in their milk after vaccination, which has
informed antenatal vaccination programs for diseases such as influenza and pertussis …

COVID-19 vaccine mRNABNT162b2 elicits human antibody response in milk of breastfeeding women

M Guida, D Terracciano, M Cennamo, F Aiello… - Vaccines, 2021 - mdpi.com
Objective: The objective of this research is to demonstrate the release of SARS-CoV-2 Spike
(S) antibodies in human milk samples obtained by patients who have been vaccinated with …

[HTML][HTML] Serum and breastmilk SARS-CoV-2 specific antibodies following BNT162b2 vaccine: prolonged protection from SARS-CoV-2 in newborns and older children

A Ricciardi, P Zelini, I Cassaniti, MA Avanzini… - International Journal of …, 2022 - Elsevier
Objectives Vaccination is the best strategy against COVID-19. We aimed to determine
antibodies against SARS-CoV-2 in breastmilk and serum of mothers vaccinated with the …

Increase in SARS-CoV-2 RBD-specific IgA and IgG antibodies in human milk from lactating women following the COVID-19 booster vaccination

AM Henle - Journal of Human Lactation, 2023 - journals.sagepub.com
Background: The United States Centers for Disease Control and Prevention recommended
a third dose or booster of the Pfizer-BioNTech Comirnaty (BNT162b2) COVID-19 mRNA …

[HTML][HTML] COVID-19 mRNA vaccination in lactation: assessment of adverse events and vaccine related antibodies in mother-infant dyads

Y Golan, M Prahl, AG Cassidy, C Gay, AHB Wu… - Frontiers in …, 2021 - frontiersin.org
Background Data regarding symptoms in the lactating mother-infant dyad and their immune
response to COVID-19 mRNA vaccination during lactation are needed to inform vaccination …

The levels of SARS-CoV-2 specific antibodies in human milk following vaccination

HG Juncker, SJ Mulleners, MJ van Gils… - Journal of Human …, 2021 - journals.sagepub.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are
being administered around the world; however, lactating women were excluded from SARS …